Top Markets
Coin of the day
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
Ранг среди акций #15970
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Цена акции
$15.42
Рыночная капитализация
$320.83M
Изменение (1 день)
-1.52%
Изменение (1 год)
40.67%
Страна
IT
Торговля Newron Pharmaceuticals S.p.A. (NP5)

Категория

Коэффициент P/B для Newron Pharmaceuticals S.p.A. (NP5)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Newron Pharmaceuticals S.p.A., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Newron Pharmaceuticals S.p.A. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH